Efficacy and Safety of Low Dose Naltrexone for Chronic Pain-Reference-Cited by-同舟云学术

Efficacy and Safety of Low Dose Naltrexone for Chronic Pain

Published:2024-02 Issue: Volume: Page:1-7
ISSN:1536-0288
Container-title:Journal of Pain & Palliative Care Pharmacotherapy
language:en
Short-container-title:Journal of Pain & Palliative Care Pharmacotherapy

Author:

N. Irwin Madison¹²^ORCID,A. Cooke David³,Berland Daniel³,D. Marshall Vincent¹,A. Smith Michael¹²^ORCID

Affiliation:

1. Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA

2. University of Michigan Health Department of Pharmacy, Ann Arbor, Michigan, USA

3. University of Michigan Health System, Division of General Medicine, Ann Arbor, Michigan, USA

Funder

Duellman Graduate Student Research Fund at the University of Michigan College of Pharmacy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Anesthesiology and Pain Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15360288.2024.2302550

Reference27 articles.

1. Duramed Pharmaceuticals. Revia drug insert. New York: Medical Sciences; 2013.

2. Low-Dose Naltrexone (LDN)—review of therapeutic utilization;Toljan K;Med Sci,2018

3. Low-Dose Naltrexone for the Treatment of Fibromyalgia: Investigation of Dose–Response Relationships

4. A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study

5. Bihari B Drury FM Ragone VP Ottomanelli GA Buimovici-Klein E Orbe MG Foeste WF Thomas JR Kirk RP Low dose naltrexone in the treatment of acquired immune deficiency syndrome. Poster presentation at the IV international AIDS conference Stockholm Sweden; 1988.